Twist Bioscience Corp (TWST) Stock Price Today
Aura AI Summary
Key Stats
- $5.75BMarket Cap
- -Volume
- HealthSector
- $102.8852W High
- $24.1652W Low
- -Typical Hold Time
- $5.68BEnterprise Value
- -Div Yield
- -Trading Activity
Track Twist Bioscience Corp (TWST) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Twist Bioscience Corp has traded between a low of $24.16 and a high of $102.88, highlighting its annual price range. Buy and sell Twist Bioscience Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Most Recent News
Class action lawsuit filed against PROCEPT BioRobotics over alleged misleading sales and inventory practices.
Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation and its executives, accusing them of misleading investors by inflating sales figures through an undisclosed discount program that caused excess ...

Stocks surge as AI data center plans, IPO debut, and strong earnings drive big gains today
Stocks of several companies jumped significantly today due to key corporate developments. STAK Inc. led with a 596% rise after announcing a U.S. subsidiary to develop power systems for AI data centers, highlighting investor interest in AI infrastruct...

Stocks of Faraday Future and Zevra Therapeutics plunge amid regulatory and investor concerns.
Faraday Future Intelligent Electric Inc. saw its stock drop nearly 40% despite recent product showcases, indicating investor worries beyond its new offerings. Zevra Therapeutics' shares fell almost 24% after the European Medicines Agency issued a neg...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.